Impact of genotypic variability of measles virus T-cell epitopes on vaccine-induced T-cell immunity

Publication date

2025-12

Authors

Emmelot, Maarten E.
Bodewes, RogierISNI 0000000396593666
Maissan, Cyril
Vos, Martijn
de Swart, Rik L.
van Els, Cécile A.C.M.ISNI 0000000388792817
Kaaijk, Patricia

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

cc_by_nc_nd

Abstract

After the COVID-19 pandemic, significant increases in measles cases were observed globally. Community-wide vaccination remains the most effective strategy for preventing measles. However, it is crucial to understand whether prevalent genotypes, when circulating in populations with suboptimal vaccination coverage, may undergo adaptive mutations that allow them to escape vaccine-induced immunity. In this study, a bioinformatics-guided approach was used to predict universal helper T-cell epitopes specific to the measles vaccine virus (vaccine-MeV) presented by multiple HLA-DR, -DP, and -DQ alleles to achieve population-wide coverage. By using MeV-specific T-cell lines, we identified 37 functional epitopes out of 83 predicted candidates, including 25 novel ones. Strikingly, 73% of these epitope regions were associated with sequence variations in wild-type viruses. More importantly, we demonstrated that mutations disrupted the ability of vaccine-induced CD4+ T cells to respond to circulating viruses. Consequently, mutations in epitope regions of circulating viruses may affect the effectiveness of vaccine-induced T-cell immunity.

Keywords

Immunology, Pharmacology, Infectious Diseases, Pharmacology (medical), SDG 3 - Good Health and Well-being

Citation

Emmelot, M E, Bodewes, R, Maissan, C, Vos, M, de Swart, R L, van Els, C A C M & Kaaijk, P 2025, 'Impact of genotypic variability of measles virus T-cell epitopes on vaccine-induced T-cell immunity', npj Vaccines, vol. 10, no. 1, 36. https://doi.org/10.1038/s41541-025-01088-y